Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study efficacy and the effects on quality of life in women
with ovarian cancer treated with a weekly schedule of chemotherapy with carboplatin and
paclitaxel compared to those treated with standard every 3 weeks schedule of the same
chemotherapy.